Assem Thabet | Nanosensors and Actuators | Best Scholar Award

Prof. Dr. Assem Thabet | Nanosensors and Actuators | Best Scholar Award

Director of Studies, Research Lab MACS, University of Gabes, Tunisia

Prof. Dr. Assem Thabet is a distinguished researcher in Electrical Engineering, with a focus on Automatic Control, Industrial Computing, and Cyber–Physical Systems. His research bridges advanced control theory, system modeling, artificial intelligence, and renewable energy integration. A key area of his expertise lies in state estimation, nonlinear dynamic system control, and reciprocal state representation, where he has made notable theoretical and applied contributions. His recent book, The Reciprocal State Representation: Some Elements for the Control of Nonlinear Dynamic Systems (ISTE Group Editions, 2025), encapsulates innovative methodologies for enhancing system controllability and observer design in nonlinear environments. Prof. Dr. Assem Thabet’s research activities span multiple international collaborations across Tunisia, France, Canada, India, Italy, Algeria, and Spain, contributing to projects on AI-driven resource management, hybrid renewable energy systems, bio-inspired robotics, and smart grid optimization. His work often integrates machine learning with estimation and control theory, applying hybrid computational models to achieve system resilience under uncertain and cyber-threatened environments. With over 50 scientific publications, including 15+ papers in indexed international journals, 15+ international conference papers, and several book chapters, his scholarly influence is well-established. His studies on observer-based control, event-triggered mechanisms, and cyber-attack detection in industrial and power systems reflect his ongoing pursuit of intelligent and secure automation. Prof. Dr. Assem Thabet’s research output has garnered 125 citations across 32 documents, with an h-index of 7, reflecting the growing recognition of his scientific impact. His most recent works—such as Cyber-Attack Detection Strategy with Markovian Distribution Logic in Cyber-Physical Systems and Event-Triggered Observer-Based Control for Enhancing Resilience under Markovian Cyberattacks-demonstrate a deep engagement with contemporary challenges in resilient control and cyber-physical system security. Through his integrative and interdisciplinary approach, Prof. Dr. Assem Thabet continues to advance the frontier of intelligent control systems and sustainable automation technologies.

Profile: Scopus | ORCID | ResearchGate | Sci Profiles | IEEE Xplore | Academia | Web of Science

Featured Publications

  1. Thabet, A., Hassine, E., Gasmi, N., & Bel Haj Frej, G. (2025). Design and real-time application of explicit model-following techniques for nonlinear systems in reciprocal state space. Electronics, 14(20), 4089.

  2. Hassine, E., Thabet, A., Gasmi, N., & Bel Haj Frej, G. (2025). An event-triggered observer-based control approach for enhancing resilience of cyber–physical systems under Markovian cyberattacks. Actuators, 14(8), 412.

  3. Thabet, A., Bel Haj Frej, G., Gasmi, N., Mansouri, K., & Chauveau, E. (2022). State and output feedback control for Lipschitz nonlinear systems in reciprocal state space: Synthesis and real-time validation. Bulletin of Electrical Engineering and Informatics, 11(5), 2702–2712.

  4. Gasmi, N., Boutayeb, M., Thabet, A., Bel Haj Frej, G., & Aoun, M. (2021). Robust control of a class of nonlinear discrete-time systems: Design and experimental results on a real-time emulator. Actuators, 10(11), 303.

  5. Hassine, E., Thabet, A., Gasmi, N., Bel Haj Frej, G., & Metoui, B. (2023). Cyber-attack tolerant control of complex interconnected systems: Output feedback stabilization approach. In Proceedings of the 2023 IEEE International Workshop on Mechatronics Systems Supervision (IW_MSS 2023) (pp. 1–5). IEEE.

Dr. Yuki Yoshimatsu | Nanoscale | Women Researcher Award

Dr. Yuki Yoshimatsu | Nanoscale | Women Researcher Award

Dr. Yuki Yoshimatsu at Tochigi Cancer Center, Japan

Dr. Yuki Yoshimatsu is a leading cancer biologist and Project Leader at the Tochigi Cancer Center Research Institute, Japan. She holds a Ph.D. in Medical Science from the University of Tokyo and has extensive experience in rare cancer research, particularly sarcomas. Her career includes senior roles at the National Cancer Center Research Institute in Tokyo and postdoctoral training at the University of Washington, USA. Her research focuses on patient-derived cancer models, drug sensitivity screening, kinomic profiling, and biomarker discovery for precision oncology. She has established over 100 rare cancer models and contributed to national clinical guidelines. Dr. Yoshimatsu is also committed to mentoring young female scientists and advancing translational oncology through international collaboration.

Professional Profile:

ORCID

Summary of Suitability for Women Researcher Award: Dr. Yuki Yoshimatsu

Dr. Yuki Yoshimatsu exemplifies excellence in biomedical research and leadership in translational oncology, making her a highly deserving candidate for the Women Researcher Award. With a Ph.D. in Medical Science from the University of Tokyo and extensive research experience at prestigious institutions including the National Cancer Center Japan and the University of Washington, Dr. Yoshimatsu has established herself as a leading figure in rare cancer biology.

🎓 Education

Ph.D. in Medical Science
🏛️ University of Tokyo, Graduate School of Medicine
🧬 Department of Pathology
📍 Tokyo, Japan

💼 Professional Experience

Project Leader
🏥 Tochigi Cancer Center Research Institute
📍 Tochigi, Japan | ⏳ 2022 – Present
🔬 Leading translational research in rare cancers and biomarker development

Senior Researcher
🧪 National Cancer Center Research Institute
📍 Tokyo, Japan | ⏳ 2016 – 2022
🧫 Established multiple patient-derived sarcoma models and conducted drug sensitivity profiling

Postdoctoral Fellow
🧬 University of Washington, Dept. of Otolaryngology
📍 Seattle, WA, USA | ⏳ 2012 – 2016
🌎 International research in viral oncogenesis and multi-step carcinogenesis

🧪 Research Interests

🧫 Rare cancers (esp. sarcomas)

🧬 Patient-derived cancer models (cell lines, organoids, xenografts)

💊 Drug sensitivity screening & kinomic profiling

🧠 Biomarker discovery for precision oncology

🦠 Viral oncogenesis & multi-step carcinogenesis

🏆 Honors & Awards

🥇 Best Presentation Award
“Establishment and characterization of a novel leiomyosarcoma cell line”
📅 Aug 2023 | 🧬 Japanese Society of Human Cell Science

🏅 Poster Award
“Construction of patient-derived sarcoma models”
📅 Nov 2021 | 🔬 Japan Society for Patient-Derived Cancer Models

🌍 International Research Grant
“Mechanisms of multi-step carcinogenesis in cervical cancer”
📅 Mar 2010 | 🧪 Kanzawa Medical Research Promotion Foundation

Publication Top Notes

Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans

Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1